In Re: Ethicon, Inc.

E-Law Admin/ Januar 3, 2017/ Arzneimittelrecht Schweiz/ 0Kommentare

In Re: Ethicon, Inc., 2015-1696

In an appeal of a merged inter partes reexamination, the USPTO Patent Trial and Appeal Board’s decision affirming the examiner’s obviousness rejection of claims of a patent, which relates to intraluminal medical devices for the local delivery of drugs, e.g., drug-eluting stents, and methods for maintaining drugs on those devices, is affirmed where the Board did not err in its obviousness conclusion.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2017/01/03



  • United States Federal Circuit


e-Law Trainer

Share this Post

Hinterlasse einen Kommentar